Foley Secures Rare Inter Partes Review Wins for Patent Owner Supernus Pharmaceuticals
10 December 2014
Foley secured three significant inter partes review victories on behalf of Supernus Pharmaceuticals, Inc. and Galderma S.A. for a pharmaceutical product, which represents one of the first inter partes reviews to reach a final decision in favor of the patent owner, where the patents were the subject of a parallel Hatch-Waxman patent litigation. The inter partes reviews were filed by a “generic” company that filed an Abbreviated New Drug application to market a generic version of the product Oracea®.
The Foley team, led by Stephen Maebius, included Andrew Baluch, George Quillin, and Sunit Talapatra.
People
Related News
11 July 2024
Press Releases
Foley Expands Health Care Capabilities with National Team of Corporate and Regulatory Lawyers, Simultaneously Opens Office in Raleigh
Foley announced today that the firm strengthened its Health Care & Life Sciences Sector, adding a group of attorneys and opening a new office in Raleigh, N.C.
26 June 2024
Press Releases
Patrick Daugherty Joins Global Digital Asset and Cryptocurrency Association Steering Committee
Foley & Lardner LLP is pleased to announce that partner Patrick Daugherty is among a select group of distinguished scholars and senior legal
17 June 2024
Press Releases
Foley Expands Texas Presence and Capabilities Across Key Sectors with Addition of Three Attorneys
Foley & Lardner LLP bolstered its Texas presence with the addition of three seasoned attorneys across its Litigation and Business Law Departments. Trey McDonald and James McFall join the firm’s Houston and Dallas offices, respectively, as partners in the Business Litigation & Dispute Resolution Practice and Innovative Technology Sector. Ronald Green, an of counsel with extensive experience in public finance, recently joined the firm’s Finance Practice Group in Houston.